国产av不卡一区二区_欧美xxxx做受欧美_成年人看的毛片_亚洲第一天堂在线观看_亚洲午夜精品久久久中文影院av_8x8ⅹ国产精品一区二区二区_久久精品国产sm调教网站演员_亚洲av综合色区无码一二三区_成人免费激情视频_国产九九九视频

Multinational makes hepatitis B antidote in China
( 2001-11-13 09:55 ) (8 )

A drug for curing hepatitis B, made in China by global pharmaceutical giant GlaxoSmithKline, will go on sale in pharmacies in the Chinese mainland this month.

Heptodin, one of the major drugs produced by GlaxoSmithKline, has been approved for sale on the mainland, according to a corporate executive for Asia and Pacific operations with the company at a news briefing held over the weekend in Guangzhou, capital of Guangdong Province.

Chinese patients suffering from hepatitis B previously relied on imported heptodin to cure their disease, but the cost of the medicine was high"GlaxoSmithKline spent 1.2 billion yuan (about 145 million US dollars) to build a heptodin production base in Suzhou Industrial Park, east China's Jiangsu Province.

With the localization, the retail price for 100-tablet boxes of heptodin go down to 242 yuan (about 29.2 US dollars), said sources from the news briefing.

Hepatitis B, which has been listed by the World Health Organization (WHO) as one of the world's nine major fatal diseases, is mainly transmitted via blood transmission and body fluid.

Guangdong ranks first in China, with the hepatitis B incidence rate amounting to 17.85 percent.